[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350990-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-350990-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","solute-carrier-family-slc-amino-acid-transporters-are-upregulated-in-cutaneous-squamous-cell-carcinoma","Solute carrier family (SLC) amino acid transporters are upregulated in cutaneous squamous cell carcinoma","","Solute carrier family (SLC) amino acid transporters support a continuous nutrient supply for cancer cells. Non-melanoma skin tumors undergo metabolic rewiring, yet the contribution of amino acid transporters and their therapeutic value in non-melanoma skin cancer remain unclear. Using publicly available transcriptomics, the study identifies multiple transporters strongly upregulated in skin cancer, highlights LAT1 in basal-like proliferating cells, and shows dependence on citrulline import under arginine scarcity. Pharmacologic LAT1 inhibition sensitizes cells to arginine deprivation, suggesting LAT1 as a therapeutic target.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/solute-carrier-family-slc-amino-acid-transporters-are-upregulated-in-cutaneous-squamous-cell-carcinoma/350990/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/solute-carrier-family-slc-amino-acid-transporters-are-upregulated-in-cutaneous-squamous-cell-carcinoma/350990.png","ImageObject",300,407,{"name":42,"@type":43},"Aria","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study’s main focus regarding SLC amino acid transporters?","Question",{"text":63,"@type":64},"It evaluates whether amino acid transporters, especially LAT1, are upregulated in cutaneous squamous cell carcinoma and whether they affect tumor survival and growth.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does LAT1 behave during epidermal differentiation in skin tumors?",{"text":68,"@type":64},"LAT1 is overexpressed in proliferating basal-like cells within skin tumors and decreases during epidermal differentiation.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is LAT1 important under low-arginine conditions?",{"text":72,"@type":64},"cSCC cells rely on citrulline to survive when arginine is scarce, and LAT1 is essential for citrulline import.",{"name":74,"@type":61,"acceptedAnswer":75},"How does inhibiting LAT1 affect tumor cells?",{"text":76,"@type":64},"Pharmacological inhibition of LAT1 with JPH203 sensitizes cells to arginine deprivation, supporting LAT1 as a potential therapeutic target.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},350990,1790470768,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,124,127,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":122,"slug":123},9,"Religion & Spirituality",20,"religion-spirituality",{"id":122,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":122,"slug":126},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":116,"language":143,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":12,"update_tm":147,"read_time":122,"preview_page_count":33,"preview_urls":148},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Petrilli et al. Biology Direct (2026) 21:17 [https://doi.org/10.1186/s13062-025-00722-y](https://doi.org/10.1186/s13062-025-00722-y)  \nBiology Direct  \nRESEARCH Open Access  \nSolute carrier family (SLC) amino acid transporters are upregulated in cutaneoussquamous cell carcinoma  \nAlessia Petrilli1, Damiano Barnaba1, Mara Mancini1,2, Luca Fania2, Francesco Ricci2, Elena Dellambra2, Gerry Melino1, Eleonora Candi1,2 and Artem Smirnov1,2*  \nAbstract  \nSolute carrier family (SLC) amino acid transporters play key role in maintaining a continuous supply of nutrients to cancer cells. Non melanoma skin tumours, the most common cancer type worldwide, undergo extensive metabolic rewiring to survive under hostile conditions. To adapt to nutrient-poor microenvironment, tumour cells often boost expression of the key metabolic enzymes. However, the role of the amino acid transporters and their therapeutic potential in non-melanoma skin cancer remain unclear. Here, we analyse publicly available transcriptomics data and identify several amino acid transporters that are strongly upregulated in skin cancer, including neutral amino acid transporter LAT1 . LAT1 is overexpressed in proliferating basal-like cells within skin tumours and its level decreases during epidermal differentiation. Furthermore, we show that cutaneous squamous cell carcinoma cells rely on citrulline to survive under arginine scarcity and LAT1 is essential for citrulline import. Pharmacological inhibition of LAT1 by the small compound JPH203 sensitises cells to arginine deprivation. Altogether, we show that amino transporter LAT1 plays an important role in cutaneous squamous cell carcinoma growth in low arginine conditions and highlight its potential as a therapeutic target.  \nKeywords Skin cancer, LAT1, Amino acid metabolism, Arginine  \nIntroducton  \nNon melanoma skin cancer is the most common type of cancer worldwide. Cutaneous squamous cell carcinoma (cSCC) accounts for approximately 20% of skin diseases. The main risk factors include excessive ultraviolet exposure, age and smoking. cSCC tumorigenesis is a multistep process of malignant transformation starting from precancerous actinic keratosis leading to an invasive SCC  \n*Correspondence:  \nArtem Smirnov  \n[artem.smirnov@uniroma2.it](artem.smirnov@uniroma2.it)  \n1Dept. of Experimental Medicine, University of Rome Tor Vergata, TOR, Rome 00133, Italy  \n2Biochemistry Laboratory, Istituto Dermopatico Immacolata (IDI-IRCCS), Rome 00144, Italy  \n[1, 2].The first-line treatment for cSCC remains surgical excision [3], however patients with aggressive forms of cSCC may require radiotherapy or chemotherapy treatment [4]. The current research is focused on the development of new therapeutic strategies for curing advanced cSCC and preventing the recurrence after surgical excision of high risk cSCC [5].  \ncSCC are characterised by high mutation burden. TP53 is the most frequently mutated gene in cSCC [6] and loss of its tumour suppressive functions leads to uncontrolled cell proliferation, resistance to apoptosis, impaired DNA damage response and genomic instability [7] Perturbation of p16/Rb pathway caused by the loss of CDKN2A result in the release of E2F transcription factors and boost of the G1/S transition [8]. Increased proliferation  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line t","cbCaitZNTYpiXJze","https://ap.wps.com/l/cbCaitZNTYpiXJze","pdf",3846056,"English","# Abstract\n## Disease background: non-melanoma skin cancer and cSCC\n## Study rationale and metabolic rewiring\n## Amino acid transporter families (SLC) and key transporters\n## LAT1 expression and function in skin tumors\n## Citrulline dependence under arginine scarcity and LAT1 requirement\n## Therapeutic implication: LAT1 inhibition with JPH203","[{\"question\":\"What is the study’s main focus regarding SLC amino acid transporters?\",\"answer\":\"It evaluates whether amino acid transporters, especially LAT1, are upregulated in cutaneous squamous cell carcinoma and whether they affect tumor survival and growth.\"},{\"question\":\"How does LAT1 behave during epidermal differentiation in skin tumors?\",\"answer\":\"LAT1 is overexpressed in proliferating basal-like cells within skin tumors and decreases during epidermal differentiation.\"},{\"question\":\"Why is LAT1 important under low-arginine conditions?\",\"answer\":\"cSCC cells rely on citrulline to survive when arginine is scarce, and LAT1 is essential for citrulline import.\"},{\"question\":\"How does inhibiting LAT1 affect tumor cells?\",\"answer\":\"Pharmacological inhibition of LAT1 with JPH203 sensitizes cells to arginine deprivation, supporting LAT1 as a potential therapeutic target.\"}]","Solute carrier family (SLC) amino acid transporters are upregulated in cutaneous squamous cell carcinoma | PDF",1790092215,[149,153,157,161],{"page_no":22,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a44464b19d46ec100c9073b65d72cc38.webp",983,1310,{"page_no":26,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7bb9eea1b64b3d062d7e8d8126228f19.webp",982,1309,{"page_no":30,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ed58fea3c60a8c3c7e085d92b77bee7a.webp",981,1308,{"page_no":33,"url":162,"width":163,"height":164},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/134cabf2355774191182da4d20162136.webp",980,1306]